Literature DB >> 32051807

Role of miR-18a and miR-25 disruption and its mechanistic pattern in progression of liver cancer.

Yijie Lu1, Zhai Min1, Ancheng Qin1, Jianwu Wu1, Xinwei Jiang1, Zhiming Qiao1.   

Abstract

This study examined the molecular mechanisms underlying the roles of the microRNAs miR-18a and miR-25 in the progression of human liver cancer. Liver cancer biopsies obtained from early-stage liver cancer patients were examined by qRT-PCR and Northern blotting to examine the expression of miR-18a and miR-25. Both microRNAs were overexpressed in mouse primary hepatocytes following transfection of the cells with vectors encoding the microRNAs. An analysis of biopsy samples from liver cancer patients indicated that both miR-18a and miR-25 were overexpressed during the early stages of liver cancer. Further, qRT-PCR and Northern blotting confirmed that both of these microRNAs play crucial roles in the progression of liver cancer. Our findings clearly indicate that miR-18a and miR-25 can be used as prognostic biomarkers for early-stage liver cancer. Hence, miR-18a and miR-25 may have value as prognostic indicators and may facilitate the development of novel therapeutics for liver cancer. © King Abdulaziz City for Science and Technology 2020.

Entities:  

Keywords:  Liver cancer; Northern blotting; miR-18a; miR-25; qRT-PCR

Year:  2020        PMID: 32051807      PMCID: PMC6987266          DOI: 10.1007/s13205-020-2064-2

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.406


  23 in total

Review 1.  Focus on hepatocellular carcinoma.

Authors:  Jordi Bruix; Loreto Boix; Margarita Sala; Josep M Llovet
Journal:  Cancer Cell       Date:  2004-03       Impact factor: 31.743

2.  Down regulation of miR-18a, miR-21 and miR-221 genes in gastric cancer cell line by chrysin-loaded PLGA-PEG nanoparticles.

Authors:  Farideh Mohammadian; Yones Pilehvar-Soltanahmadi; Mohsen Mofarrah; Mehdi Dastani-Habashi; Nosratollah Zarghami
Journal:  Artif Cells Nanomed Biotechnol       Date:  2016-01-15       Impact factor: 5.678

Review 3.  Hepatocellular carcinoma pathogenesis: from genes to environment.

Authors:  Paraskevi A Farazi; Ronald A DePinho
Journal:  Nat Rev Cancer       Date:  2006-09       Impact factor: 60.716

Review 4.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

5.  Identification of local and circulating cancer stem cells in human liver cancer.

Authors:  Zhen Fan Yang; Patricia Ngai; David W Ho; Wan Ching Yu; Michael N P Ng; Chi Keung Lau; Mandy L Y Li; Ka Ho Tam; Chi Tat Lam; Ronnie T P Poon; Sheung Tat Fan
Journal:  Hepatology       Date:  2008-03       Impact factor: 17.425

6.  Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties.

Authors:  C Coulouarn; V M Factor; J B Andersen; M E Durkin; S S Thorgeirsson
Journal:  Oncogene       Date:  2009-07-20       Impact factor: 9.867

Review 7.  Experimental mouse models for hepatocellular carcinoma research.

Authors:  Femke Heindryckx; Isabelle Colle; Hans Van Vlierberghe
Journal:  Int J Exp Pathol       Date:  2009-08       Impact factor: 1.925

8.  Functional microRNA library screening identifies the hypoxamir miR-24 as a potent regulator of smooth muscle cell proliferation and vascularization.

Authors:  Jan Fiedler; Andrea Stöhr; Shashi Kumar Gupta; Dorothee Hartmann; Angelika Holzmann; Annette Just; Arne Hansen; Denise Hilfiker-Kleiner; Thomas Eschenhagen; Thomas Thum
Journal:  Antioxid Redox Signal       Date:  2013-11-19       Impact factor: 8.401

9.  Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation.

Authors:  Carlos le Sage; Remco Nagel; David A Egan; Mariette Schrier; Elly Mesman; Annunziato Mangiola; Corrado Anile; Giulio Maira; Neri Mercatelli; Silvia Anna Ciafrè; Maria Giulia Farace; Reuven Agami
Journal:  EMBO J       Date:  2007-07-12       Impact factor: 11.598

10.  MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.

Authors:  Wan-Hsin Liu; Shiou-Hwei Yeh; Cho-Chun Lu; Sung-Liang Yu; Hsuan-Yu Chen; Chien-Yu Lin; Ding-Shinn Chen; Pei-Jer Chen
Journal:  Gastroenterology       Date:  2008-11-01       Impact factor: 22.682

View more
  2 in total

1.  Robust Biomarker Screening Using Spares Learning Approach for Liver Cancer Prognosis.

Authors:  Aman Chandra Kaushik; Aamir Mehmood; Dong-Qing Wei; Xiaofeng Dai
Journal:  Front Bioeng Biotechnol       Date:  2020-04-03

2.  Exosomes derived from microRNA-129-5p-modified tumor cells selectively enhanced suppressive effect in malignant behaviors of homologous colon cancer cells.

Authors:  Yong Ji; Jianxiang Ji; Hongming Yin; Xu Chen; Pengcheng Zhao; Huahu Lu; Taowu Wang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.